|
Blood donation helps save Claiborne County baby’s life
WATE-TV Makayla Beth and Weston Shipley of Claiborne County are a cute young couple who just welcomed their baby Jaycee May on November 21. While Jaycee May is doing well today, technically she shouldn’t be here yet. She wasn’t due until January 24. |
Toughest Carolina Panther? 15-month-old TJ Olsen – USA TODAY
|
Toughest Carolina Panther? 15-month-old TJ Olsen
USA TODAY Richardson underwent 2009 heart transplant surgery at the same hospital that treated Olsen’s son and where Denver Broncos coach John Fox went this past season. “We gave T.J. the middle name ‘Jerry’ because of the way Mr. Richardson helped us when … |
'Rock-n-Roll Up Your Sleeves' Blood Donation Drive at Cavenders – KRIS Corpus Christi News
|
‘Rock-n-Roll Up Your Sleeves’ Blood Donation Drive at Cavenders
KRIS Corpus Christi News The Coastal Bend Blood Center is in need of donations. This time of year especially, with everyone busy with the holidays, bad weather, and illness. On Saturday, January 11th, they’d be happy to accept your donations at the ‘Rock-n-Roll Up Your Sleeve’ … |
Scientific symposium of cardiologists begins – Times of India
Scientific symposium of cardiologists beginsTimes of IndiaDuring the conference ECMO (Extra Corporeal Membrane Oxygenation), extracorporeal life support system was also launched in Gujarat, Rajasthan and Madhya Pradesh. ECMO is a portable heart-lung by…
Lithium May Help Treat Acute Kidney Injury – Counsel & Heal
Counsel & Heal |
Lithium May Help Treat Acute Kidney Injury
Counsel & Heal Mood stabilizer drugs like lithium may help treat acute kidney injury, according to a new study. Researchers said the findings are important because there are no effective therapies for acute kidney injury. Acute kidney injury is becoming increasing … Mood stabilizing drug may help treat acute kidney injuryEurekAlert (press release) Lithium May Promote Recovery in Acute Kidney InjuryDoctors Lounge Ray of hope for kidney patientsDaily News & Analysis |
Start of stem-cell study offers hope to patients with spinal-cord injuries – CTV News
CTV NewsStart of stem-cell study offers hope to patients with spinal-cord injuriesCTV NewsA team of doctors at the University of Calgary has, for the first time in North America, successfully performed a stem cell transplant in a spinal cord injury pat…
The Ethics Of Being Brain Dead: Doctors And Bioethicists Discuss Jahi McMath … – Huffington Post
|
The Ethics Of Being Brain Dead: Doctors And Bioethicists Discuss Jahi McMath …
Huffington Post Many people don’t understand the differences between a coma, persistent vegetative state and brain death, said Arthur Caplan, head of the division of bioethics at NYU Langone Medical Center in New York City. By moving the lungs up and down, a … |
Brain Death Raises Tough Questions – National Geographic
National Geographic |
Brain Death Raises Tough Questions
National Geographic For 13-year-old Jahi McMath of Oakland, California, brain death was declared in the wake of complications from surgery. Her parents have fought to keep her on life support, contending that the functioning of her heart and lungs indicates she is still … Jahi McMath brain death case: Family’s attorney defends his actionsLos Angeles Times The Science Behind Brain DeathNew York Times NEW: Two cases raise questions of how brain death is determinedSarasota Herald-Tribune San Jose Mercury News –NBC Bay Area –Newsday all 57 news articles » |
Arca Biopharma Inc (ABIO): Arca Biopharma: A Genetically Targeted Drug For … – Seeking Alpha
Arca Biopharma Inc (ABIO): Arca Biopharma: A Genetically Targeted Drug For …Seeking AlphaA Colorado-based biopharmaceutical company, Arca Biopharma (ABIO), has a genetically-targeted drug, Gencaro (bucindolol hydrochloride), for Atrial fibrillation (…
Biologic Makers Thwart Generics: Winning Stocks [Pfizer Inc., Amgen, Inc … – Seeking Alpha
|
Biologic Makers Thwart Generics: Winning Stocks [Pfizer Inc., Amgen, Inc …
Seeking Alpha Hospira (HSP) and Teva halted late-stage development of follow-on versions of Roche AG’s monoclonal antibody Rituxan (rituximab) — $3.1 billion in domestic sales, trailing 12-months – due to rising R&D costs. Similar to strategies used to delay entry … |